H.C. Wainwright analyst Edwin Zhang downgraded Liminal BioSciences, Inc. (NASDAQ: LMNL) from Buy to Neutral.The analyst comments "As expected, Kedrion ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE